|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-1-27
|
|
pubmed:abstractText |
The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment (ovariectomy, tamoxifen) this disease is often refractory to therapy and almost inevitably leads to the patient's death. We describe a case where the antiproliferative effect of systemically applied interferon alpha 2b was successfully employed in addition to ovariectomy and the patient reached complete remission.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0932-0067
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
252
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
99-102
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1471918-Adult,
pubmed-meshheading:1471918-Chylothorax,
pubmed-meshheading:1471918-Combined Modality Therapy,
pubmed-meshheading:1471918-Female,
pubmed-meshheading:1471918-Humans,
pubmed-meshheading:1471918-Hysterectomy,
pubmed-meshheading:1471918-Interferon-alpha,
pubmed-meshheading:1471918-Lymphangiomyoma,
pubmed-meshheading:1471918-Mediastinal Neoplasms,
pubmed-meshheading:1471918-Ovariectomy,
pubmed-meshheading:1471918-Pelvic Neoplasms,
pubmed-meshheading:1471918-Recombinant Proteins,
pubmed-meshheading:1471918-Retroperitoneal Neoplasms,
pubmed-meshheading:1471918-Tamoxifen
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, Hanusch-Krankenhaus, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
